Chemotherapy of leprosy : report of a WHO study group [meeting held in Geneva from 1 to 5 November 1993]
Other TitlesChimiothérapie de la lèpre : rapport d' un groupe d' étude de l' OMS [réuni à Genève du 1er au 5 novembre 1993]
Quimioterapia de la lepra : informe de un grupo de estudio de la OMS
AbstractEvaluates accumulated data on the efficacy, safety, and acceptability of WHO multidrug therapy regimens for thetreatment of multi-bacillary and paucibacillary leprosy. Addressed to the managers of leprosy control programmes, the book aims to determine whether changes in these regimens, which have been widely used for more than twelve years, are needed. Noting that the effectiveness of multidrug therapy is now well established, the report concentrates on the continuing need to simplify the administration of existing drugs, to improve accessibility for patients with special needs, and to derive the maximum benefit from newly developed drugs. Throughout, emphasis is placed on changes that can provide the high quality control programmes needed to eliminate leprosy by the year 2000. The report has five sections. The first reviews findings from several studies of leprosy chemotherapy involving large numbers of patients. For multibacillary disease, the report concluded that the duration could now be fixed at 24 months and that the proviso to continue until skin smears are negative could be dropped. Concerning the treatment of paucibacillary disease, the report concluded that the six-month WHO multidrug treatment regimen has proved very effective and should continue to be used. The second section summarizes accumulated data on the safety, efficacy, optimum doses, and costs of currently available antileprosy drugs. Recommended chemotherapeutic regimens are presented in the third section. The remaining sections offer practical advice on operational issues relevant to the quality of control programmes, and review prospects for the development of new drugs
WHO Study Group on Chemotherapy of Leprosy (1993 : Geneva, Switzerland) & World Health Organization. (1994). Chemotherapy of leprosy : report of a WHO study group [meeting held in Geneva from 1 to 5 November 1993]. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/39877
WHO technical report series ; 847
MetadataShow full item record
Showing items related by title and MeSH subject.
Global leprosy strategy 2016-2020: accelerating towards a leprosy-free world - 2016 operational manual. Regional Office for South-East Asia, World Health Organization (2016-09)The "Global Leprosy Strategy 2016-2020, Accelerating towards a leprosy-free world", was officially launched on 20 April 2016. Its overall goal is to further reduce the burden of leprosy while providing more comprehensive and timely care following the principles of equity and social justice. The purpose of this Operational Manual is to provide guidance for managers of national leprosy programmes (or equivalent entities) to adapt and implement the Global Leprosy Strategy in their own countries. It follows the structure of the global ...